Zirgan Side Effects
Generic name: ganciclovir ophthalmic
Medically reviewed by Drugs.com. Last updated on Aug 10, 2023.
Note: This document contains side effect information about ganciclovir ophthalmic. Some dosage forms listed on this page may not apply to the brand name Zirgan.
Applies to ganciclovir ophthalmic: ophthalmic gel/jelly.
Serious side effects of Zirgan
Along with its needed effects, ganciclovir ophthalmic (the active ingredient contained in Zirgan) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking ganciclovir ophthalmic:
More common
- Blurred vision
- red, sore eyes
Less common
- Painful irritation of the clear front part of the eye
- redness of the white part of eyes or inside of the eyelids
For Healthcare Professionals
Applies to ganciclovir ophthalmic: intraocular implant, ophthalmic gel.
General
The following side effects are for the ophthalmic gel only; if available, the manufacturer product information for the intraocular implant should be consulted for additional information.
Ocular
Very common (10% or more): Blurred vision (60%), eye irritation (20%), transient burning/stinging sensations
Common (1% to 10%): Punctate keratitis, conjunctival hyperemia[Ref]
More about Zirgan (ganciclovir ophthalmic)
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic anti-infectives
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
References
1. Cerner Multum, Inc. UK Summary of Product Characteristics.
2. Product Information. Zirgan (ganciclovir ophthalmic). Sirion Therapeutics. 2009.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.